§ Dr. Gibson
To ask the Secretary of State for Health (1) pursuant to his answer of 5 January 2004,Official Report, column 200W, on the National Institute for 174W Clinical Excellence, when the findings of the investigation into the implementation of guidance on the use of cancer treatments produced by the National Institute for Clinical Excellence will be published; 
§ Miss Melanie Johnson
Professor Mike Richards, the National Cancer Director, is continuing his investigation into the causes of the apparent variation in the uptake of cancer drugs approved by the National Institue for Clinical Excellence.
Professor Richards is currently considering evidence provided by the 34 cancer networks in England and data supplied by the pharmaceutical industry.
Findings are expected to be available in Spring 2004.